12:00 AM
 | 
May 04, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Xiaflex regulatory update

FDA accepted for filing and granted Priority Review to a BLA from Auxilium for Xiaflex clostridial collagenase to treat Dupuytren's contracture, a condition that affects the...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >